-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
-
Summary
-
Processa Pharmaceuticals, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from Q1 2021 to Q3 2024.
- Processa Pharmaceuticals, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2024 was -1.03 USD/shares, a 33.1% increase year-over-year.
- Processa Pharmaceuticals, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2024 was -4.62 USD/shares, a 88.5% increase year-over-year.
- Processa Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2023 was -8.48 USD/shares, a 75.1% increase from 2022.
- Processa Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2022 was -34.1 USD/shares, a 4440% decline from 2021.
- Processa Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2021 was -0.75 USD/shares.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)